Filing Details
- Accession Number:
- 0001179110-14-003319
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-21 15:41:54
- Reporting Period:
- 2014-02-14
- Filing Date:
- 2014-02-21
- Accepted Time:
- 2014-02-21 15:41:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327145 | L Robin Washington | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-14 | 968 | $21.94 | 50,800 | No | 5 | A | Direct | |
Common Stock | Disposition | 2014-02-19 | 968 | $83.36 | 49,832 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- 968 shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
- The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Sale prices reported for the transactions reported here range from $82.87 to $83.74. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.